Kineta Reports Favorable Clinical Safety And Tolerability Profile Observed With No Dose Limiting Toxicities And No Evidence Of CRS-Associated Cytokines Observed At Any Dose Level
Kineta Reports Favorable Clinical Safety And Tolerability Profile Observed With No Dose Limiting Toxicities And No Evidence Of CRS-Associated Cytokines Observed At Any Dose Level
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.